Literature DB >> 15065852

Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.

Janeen L Vanhooke1, Matthew M Benning, Cary B Bauer, J Wesley Pike, Hector F DeLuca.   

Abstract

We have determined the crystal structures of the ligand binding domain (LBD) of the rat vitamin D receptor in ternary complexes with a synthetic LXXLL-containing peptide and the following four ligands: 1alpha,25-dihydroxyvitamin D(3); 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD); 1alpha-hydroxy-2-methylene-19-nor-(20S)-bishomopregnacalciferol (2MbisP), and 2alpha-methyl-19-nor-1alpha,25-dihydroxyvitamin D(3) (2AM20R). The conformation of the LBD is identical in each complex. Binding of the 2-carbon-modified analogues does not change the positions of the amino acids in the ligand binding site and has no effect on the interactions in the coactivator binding pocket. The CD ring of the superpotent analogue, 2MD, is tilted within the binding site relative to the other ligands in this study and to (20S)-1alpha,25-dihydroxyvitamin D(3) [Tocchini-Valentini et al. (2001) Proc. Natl. Acad. Sci. U.S.A. 98, 5491-5496]. The aliphatic side chain of 2MD follows a different path within the binding site; nevertheless, the 25-hydroxyl group at the end of the chain occupies the same position as that of the natural ligand, and the hydrogen bonds with histidines 301 and 393 are maintained. 2MbisP binds to the receptor despite the absence of the 25-hydroxyl group. A water molecule is observed between His 301 and His 393 in this structure, and it preserves the orientation of the histidines in the binding site. Although the alpha-chair conformer is highly favored in solution for the A ring of 2AM20R, the crystal structures demonstrate that this ring assumes the beta-chair conformation in all cases, and the 1alpha-hydroxyl group is equatorial. The peptide folds as a helix and is anchored through hydrogen bonds to a surface groove formed by helices 3, 4, and 12. Electrostatic and hydrophobic interactions between the peptide and the LBD stabilize the active receptor conformation. This stablization appears necessary for crystal growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065852     DOI: 10.1021/bi036056y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  44 in total

1.  Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor.

Authors:  J Wesley Pike; Mark B Meyer; Makoto Watanuki; Sungtae Kim; Lee A Zella; Jackie A Fretz; Miwa Yamazaki; Nirupama K Shevde
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-12       Impact factor: 4.292

Review 2.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

3.  The vitamin D receptor interacts preferentially with DRIP205-like LxxLL motifs.

Authors:  Lee A Zella; Ching-Yi Chang; Donald P McDonnell; J Wesley Pike
Journal:  Arch Biochem Biophys       Date:  2007-01-08       Impact factor: 4.013

4.  RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.

Authors:  Waise Quarni; Panida Lungchukiet; Anfernee Tse; Pei Wang; Yuefeng Sun; Ravi Kasiappan; Jheng-Yu Wu; Xiaohong Zhang; Wenlong Bai
Journal:  J Steroid Biochem Mol Biol       Date:  2017-02-01       Impact factor: 4.292

5.  The retinoid X receptor ligand restores defective signalling by the vitamin D receptor.

Authors:  Ruth Sánchez-Martínez; Ana I Castillo; Andreas Steinmeyer; Ana Aranda
Journal:  EMBO Rep       Date:  2006-08-25       Impact factor: 8.807

Review 6.  The development of a bone- and parathyroid-specific analog of vitamin D: 2-methylene-19-Nor-(20S)-1α,25-dihydroxyvitamin D3.

Authors:  Hector F Deluca
Journal:  Bonekey Rep       Date:  2014-03-05

7.  Structure of the ligand-binding domain of rat VDR in complex with the nonsecosteroidal vitamin D3 analogue YR301.

Authors:  Shinji Kakuda; Kazuhisa Okada; Hiroshi Eguchi; Kazuya Takenouchi; Wataru Hakamata; Masaaki Kurihara; Midori Takimoto-Kamimura
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-10-31

8.  Quantification of the vitamin D receptor-coregulator interaction.

Authors:  Arnaud Teichert; Leggy A Arnold; Steve Otieno; Yuko Oda; Indre Augustinaite; Tim R Geistlinger; Richard W Kriwacki; R Kiplin Guy; Daniel D Bikle
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

9.  Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl.

Authors:  Lori A Plum; Jean M Prahl; Xiaohong Ma; Rafal R Sicinski; Sumithra Gowlugari; Margaret Clagett-Dame; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

Review 10.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.